Clinical Trials List
2018-05-01 - 2026-12-31
Phase III
Recruiting3
ICD-10C34
Malignant neoplasm of bronchus and lung
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Heng-Sheng Chao Division of Thoracic Medicine
- Yung-Hung Luo Division of Thoracic Medicine
- Yi-Chen Yeh Division of Others -
- 趙恒勝 Division of Thoracic Medicine
- 蕭慈慧 Division of Thoracic Medicine
- 黃建勝 Division of General Surgery
- Yu-Chung Wu Division of General Surgery
- Chao-Hua Chiu Division of Thoracic Medicine
- 周德盈 Division of Others -
- Hsu-ching Huang Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
2 Recruiting
Audit
None
Co-Principal Investigator
- 林理涵 Division of Radiology
- 張晃智 Division of Thoracic Medicine
- 趙東瀛 Division of Thoracic Medicine
- Shau-Hsuan Li Division of Hematology & Oncology
- 李易濰 Division of Radiology
- 賴建豪 Division of Thoracic Medicine
- 呂宏益 Division of Cardiovascular Surgery
- 林孟志 Division of Thoracic Medicine
- 王逸熙 Division of Thoracic Medicine
- 鍾聿修 Division of Thoracic Medicine
- 黃昭誠 Division of Others
- 陳彥豪 Division of Hematology & Oncology
- Chia-Cheng Tseng Division of Thoracic Medicine
- 黃國棟 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- JENG-SEN TSENG Division of Thoracic Medicine
- YEN-HSIANG HUANG Division of Thoracic Medicine
- 吳致瑩 Division of Others
- Gee-chen Chang Division of Thoracic Medicine
- 林志鴻 Division of Thoracic Surgery
- KUO-HSUAN HSU Division of Thoracic Medicine
- 陳焜結 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
374 participants
